
Adalimumab - Inflammatory bowel disease
You are here : Home > Formulary Search > Adalimumab - Inflammatory bowel disease
Status 1
- Subcutaneous injection (sc)
Documentation
PAD Profile
Other Indications
Below are listed other indications that Adalimumab is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Inflammatory bowel disease.
Committee Recommendations (2)
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the reviewed and updated IBD immunomodulator pathway, which is to be found on the IBD guidelines page.
The Medicines and Healthcare Products Regulatory Agency (MHRA) recommends to prescribe biological products by brand name to ensure that substitution of a biosimilar product does not occur when the medicine is dispensed by the pharmacist. Https://www/gov/uk/drug-safety-update/biosimilar-products
Primary care prescriber should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient's medication.